CLEANClean Science and Technology Limited
Convert to ideaChemicals & Petrochemicals · Specialty Chemicals · CRISIL: AA- (Stable)
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeUp 0.9 this quarter.
Momentum from moving averages, Supertrend and RSI.
4 forensic issues found. Sign in to see which.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
4 found · risk watch
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹299 Cr | ₹56 Cr | 23.61% | 18.61% | ₹0.00 | 39.4x |
| Q1 FY2027 | ₹268 Cr | ₹73 Cr | 28.09% | 27.33% | ₹6.90 | Negligible |
| Q4 FY2026 | ₹249 Cr | ₹58 Cr | 30.07% | 23.38% | ₹5.48 | Negligible |
| Q3 FY2026 | ₹220 Cr | ₹46 Cr | 24.09% | 20.89% | ₹4.32 | Negligible |
| Q2 FY2026 | ₹245 Cr | ₹55 Cr | 27.91% | 22.66% | ₹5.22 | Negligible |
| Q1 FY2026 | ₹243 Cr | ₹70 Cr | 33.43% | 28.85% | ₹6.59 | Negligible |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Specialty Chemicals
Compare with peers →Clean Science and Technology Limited, together with its subsidiaries, manufactures fine and specialty chemicals in India, China, the Americas, Europe, and internationally. It operates through Performance Chemicals, FMCG Chemicals, and Pharmaceutical & Agro Intermediates segments. The company offers performance chemicals, including monomethyl ether of hydroquinone, butylated hydroxy anisole, tertiary butyl hydroquinone, hindered amine light stabilisers, and butylated hydroxytoluene, as well as clean antiOX 962, 4-oxo tempo, 4-butoxy tempo, clean light stab 770, 4-hydroxy tempo, l-ascorbyl palmitate, 2,5-di-tertiary butyl hydroquinone, and dimethyl sebacate. It also provides FMCG chemicals, such as 4-methoxy acetophenone, anisole, guaiacol, butylated hydroxy anisole, l-ascorbyl palmitate, tertiary butyl hydroquinone, para di-methoxy benzene, and ortho methoxy toluene. In addition, the company offers pharmaceutical and agro intermediates, which include guaiacol, dicyclohexyl carbodiimide, veratrole, DHDT, para benzoquinone, para di-methoxy benzene, anisole, and ortho methoxy toluene. It exports its products and serves polymers, coatings, food, automotive, construction, cosmetics, personal care, fragrances, pharmaceuticals, agrochemical manufacturers, specialty chemical firms, and other industries. The company was incorporated in 2003 and is headquartered in Pune, India.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.